Capture

WHITE PAPERS AND CASE STUDIES

• Modelling TPDs Utilizing Computational And Medicinal Chemistry Approaches

  Through a carefully executed strategy, see how we identified novel degrader molecules with the right physicochemical properties to achieve robust degradation of the target Protein of Interest (POI).

• Laerdal Error-Proofs Medical Kit Assembly With AI-Powered Vision Verifications

  Discover how Laerdal Medical implemented an automated kit assembly solution that enhances quality control and supports continuous improvement through real-time monitoring and visual documentation.

• TOC Reduction For Solar Photovoltaic Plant

  Atlantium Technologies installed UV systems in an Indian solar photovoltaic manufacturing plant to remove impurities from ultrapure water, effectively reducing TOC levels and providing high microbial reduction. Their HOD UV technology has been proven effective in water treatment.

• Establishing Analytical Methods For mRNA-Based Therapies

  Here, we provide a detailed description of assays for sequence identification and LNP composition in mRNA-LNP products that support the development of safe and effective mRNA therapies.

• Mastering Technology Transfers: Our Blueprint For Success

  Uncover how this expert approach to process transfer supports reliable, scalable commercial manufacturing in the rapidly growing biopharmaceutical market.

• Pharma R&D Review 2024: Pleasant Weather Ahead

  Gain insights from the 2024 pharma landscape, which reports a record-breaking 22,825 pipeline drugs, led by Pfizer's 32 new candidates and a strong focus on oncology and neurological treatments.

• A Risk Assessment Study Of SARS-Cov-2 Propagation

  Explore the multicellular tropism of SARS-CoV-2 and the corresponding challenges for the manufacturing of cell therapies, where the material could potentially get infected at the source or during cell processing.

• The EMR Interoperability Dream Vs. Clinical Research Reality

  Seamless Electronic Medical Record access promises accelerated trials and regulatory-grade evidence, but incomplete, unstructured data requires hybrid strategies using AI and human oversight to bridge gaps.

• Managing Cash Flow And Financial Risk For Cell And Gene Therapies

  Pharmaceutical companies that are able to mitigate financial risk for CGT providers and ease cash flow burdens will stand out as preferred partners in an increasingly competitive industry.

• Vial Adapter Transfer Device Compatibility With Cell Therapies

  Needles and syringes are commonly used to retrieve cell therapies from vials, posing the risk of needle stick injury. Explore the suitability of needle-free polycarbonate transfer devices.

• Clinical Trial Disclosure Compliance: A Moving Target

  To date this year, 115 updates to clinical trial disclosure rules have been tracked across global regulatory agencies. See what types of changes have occurred, where they were, and how they are implemented.

• Strategic Space Management

  A pharmaceutical company facing storage space issues decided to outsource its reference samples to Q1 Scientific, a stability storage service provider, resulting in cost savings.